The presence of mannose-rich glycans in the S1 region of SARS-CoV-2 has raised the hypothesis that glycan recognition and binding to MBL may inhibit S1-ACE interaction, thus limiting SARS-CoV-2 infection [24]. This evidence concerns the gene MBL2 and COVID-19.